Response: Re: Dose Escalation Methods in Phase I Cancer Clinical Trials

被引：1
|
作者：
Le Tourneau, Christophe
Lee, J. Jack
Siu, Lillian L.
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 24期
关键词：
D O I：
10.1093/jnci/djp401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1733 / 1734
页数：2
相关论文
共 50 条
  • [41] A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials
    Lee, Se Yoon
    TRIALS, 2023, 24 (01)
  • [42] A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials
    Se Yoon Lee
    Trials, 24
  • [43] A phase I dose escalation trial of intravenous treosulfan in refractory cancer
    Harstrick, A
    Wilke, H
    Eberhardt, W
    Klaassen, U
    Strumberg, D
    Korn, M
    Scheulen, ME
    Baumgart, J
    Seeber, S
    ONKOLOGIE, 1996, 19 (02): : 153 - 156
  • [44] Evaluation of the cohort size in phase I dose escalation trials based on laboratory data
    Buöen, C
    Holm, S
    Thomsen, MS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (05): : 470 - 476
  • [45] Adaptive dose finding for phase I clinical trials of drugs used for chemotherapy of cancer
    Potter, DM
    STATISTICS IN MEDICINE, 2002, 21 (13) : 1805 - 1823
  • [46] Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations
    Ursino, Moreno
    Zohar, Sarah
    Lentz, Frederike
    Alberti, Corinne
    Friede, Tim
    Stallard, Nigel
    Comets, Emmanuelle
    BIOMETRICAL JOURNAL, 2017, 59 (04) : 804 - 825
  • [47] Comparison Among Modified Continual Reassessment Methods with Different Dose Allocation Methods for Phase I Clinical Trials
    Xiao, Jiacheng
    Zhang, Weijia
    Li, Rong
    Wen, Conghua
    MATHEMATICS, 2025, 13 (05)
  • [48] A SYSTEMATIC REVIEW OF THE METHODOLOGY OF FULLY PUBLISHED PHASE I RADIATION DOSE ESCALATION TRIALS IN PATIENTS WITH LUNG CANCER.
    Pijls-Johannesma, M.
    van Mastrigt, G.
    De Ruysscher, D.
    Baumert, B.
    Lammering, G.
    Buijsen, J.
    Bentzen, S.
    Hahn, S.
    Lievens, Y.
    Kramar, A.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S276 - S276
  • [49] The dose-response relationship in Phase I clinical trials and beyond: use, meaning, and assessment
    Emilien, G
    van Meurs, W
    Maloteaux, JM
    PHARMACOLOGY & THERAPEUTICS, 2000, 88 (01) : 33 - 58
  • [50] An interim analysis of a phase I dose escalation clinical trial on extracranial SBRT
    Deodato, F.
    Macchia, G.
    Cilla, S.
    Ianiro, A.
    Picardi, V.
    Ferro, M.
    Tolento, G.
    Siepe, G.
    Arcelli, A.
    Buwenge, M.
    Bisello, S.
    Maselli, G.
    Sallustio, G.
    Ciabatti, S.
    Frakulli, R.
    Cammelli, S.
    Frezza, G. P.
    Valentini, V.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S242 - S242
12345